An experimental Alzheimer's drug given just twice a year slowed cognitive decline by 54% in patients with early-stage disease, raising hopes for a powerful new treatment that could help millions preserve their memory and independence. The findings, presented this week at the...
Continue reading...
[ H/T Newsmax ]